Auszug
Nach Definition der WHO und der International Society and Federation of Cardiology von 1995 umfassen die Kardiomyopathien alle Erkrankungen des Herzmuskels, die mit einer kardialen Funktionsstörung assoziiert sind [41]. Die beiden mit Abstand häufigsten Vertreter primärer Kardiomyopathien sind die hypertrophe Kardiomyopathie (HCM), die eine Prävalenz von fast 1: 500 aufweist und die dilatative Kardiomyopathie (DCM, Prävalenz 36: 100 000). Die genaue Häufigkeit der weitaus selteneren arrhythmogenen rechtsventrikulären Kardiomyopathie (ARVC) ist nicht bekannt, während die restriktiven Kardiomyopathien nahezu eine Rarität darstellen [9, 28, 37].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A (2000) Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31:988–998
Briguori C, Betocchi S, Romano M, Manganelli F, Angela-Losi M, Ciampi Q, Gottilla R, Lombardi R, Condorelli M, Chiariello M (1999) Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol 84:309–315
Burke AP, Farb A, Tashko G, Virmani R (1998) Arrhythmogenic right ventricular cardiomyopathy and fatty replacement. Circulation 97:1571–1580
Cannon RO, McIntosh CL, Schenke WH, Maron BJ, Bonow RO, Epstein SE (1989) Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. Circulation 79:766–775
Cardim N, Oliveira AG, PhD, Longo S, Ferreira T, Pereira A, Reis RP, Correia JM (2003) Doppler tissue imaging: Regional myocardial function in hypertrophic cardiomyopathy and in athlete’s heart. J Am Soc Echocardiogr 16:223–232
Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Millaire A, Carrier L, Bonne G, Tesson F, Richard P, Bouhour JB, Schwartz K, Komajda M (1997) Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96:214–219
Corrado D, Basso C, Schiavon M, Thiene G (1998) Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339:364–369
Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, Nava A, Silvestri F, Blomstrom-Lundquist C, Wlodarska EK, Fontaine G, Camerini F (1997) Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathia/dysplasia: a multicenter study. J Am Coll Cardiol 30:1512–1520
Corrado D, Fontaine G, Marcus FI, McKenna WJ, Nava A, Thiene G, Wichter T (2000) Arrhythmogenic right ventricular cardiomyopathia/dysplasia — Need for international registry. Circulation 101:e101–e106
Dec WG, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564–1575
Deng MC, Röder N, Plenz G, Erren M, Brisse B, Soeparwata R, Scheld HH (1997) Proinflammatorische Zytokine und kardiale Pumpfunktion. Z Kardiol 86:788–802
Dickhuth H-H, Hipp A, Nieß A, Röcker K, Mayer F, Horstmann T (2001) Differenzialdiagnostik der physiologischen Herzhypertrophie (Sportherz). Dtsch Z Sportmed 52:205–210
Elliott PM (2001) The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era. Curr Cardiol Rep 3:167–172
Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ (2000) Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 36:2212–2218
Elliott PM, Gimeo Blanes JR, Mahon NG, Poloniecki J, McKenna WJ (2001) Relation between severity of left-ventricular hyperthrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357:420–424
Erbs S, Linke A, Gielen S, Fiehn E, Walther C, Yu J, Adams V, Schuler G, Hambrecht R (2003) Exercise training in patients with severe chronic heart failure: Impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial. Eur J Cardiovasc Prev Rehabil 10:336–344
Franciosa JA, Park M, Levine TB (1981) Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 47:33–39
Jansson K, Dahlstrom U, Karlsson E, Nylander E, Walfridsson H, Sonnhag C (1990) The value of exercise test, Holter monitoring, and programmed electrical stimulation in detection of ventricular arrhythmias in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 13:1261–1267
Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schächter A, Levine JH (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158
Klues HG, Schiffers A, Maron BJ (1995) Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26:1699–1708
Manyari DE, Paulsen W, Boughner DR, Purves P, Kostuk WJ (1983) Resting and exercise left ventricular function in patients with hypertrophic cardiomyopathy. Am Heart J 105:980–987
Marcus FI, Fontaine G (1995) Arrhythmogenic right ventricular dysplasia/cardiomyopathy: A review. Pacing Clin Electrophysiol 18:1298–1314
Marcus FI, Fontaine G, Guiraudon G, Frank R, Laurenceau JL, Malergue C, Grosgogeat Y (1982) Right ventricular dysplasia: A report of 24 adult cases. Circulation 65:384–398
Maron BJ (2001) The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited. Ann Noninvasive Electrocardiol 6:277–279
Maron BJ (2002) Hypertrophic cardiomyopathy — A systematic review. JAMA 13:1308–1320
Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of the distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wideangle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 48:418–428
Maron BJ, Ackermann MJ, Nishimura RA, Pyeritz RE, Towbin JA, Udelson JE (2005) Task force 4: HCM and other cardiomyopathies, mitral valve prolapse and marfan syndrome. J Am Coll Cardiol 45:1340–1345
Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation 92:785–789
Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology. Eur Heart J 24:1965–1991
Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO (1998) Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276:199–204
Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG, Seidman CE (2001) Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 38:315–321
Maron BJ, Seidman JG, Seidman CE (2004) Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 2125–2132
McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom-Lundquist C, Fontaine G, Camerini F (1994) Diagnosis of right ventricular dysplasia/cardiomyopathy. Br Heart J 71:215–218
Nava A, Bauce B, Basso C, Muriago M, Rampazzo A, Villanova C, Daliento L, Buja G, Corrado D, Danieli GA, Thiene G (2000) Clinical profile and long-term followup of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 36:2226–2233
Nelson GS, Curry CW, Wyman BT, Kramer A, Declerck J, Talbot M, Douglas MR, Berger RD, McVeigh ER, Kass DA (2000) Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 101:2703–2709
Norman MW, McKenna WJ (1999) Arrhythmogenic right ventricular cardiomyopathy: Perspectives on disease. Z Kardiol 88:550–554
Olbrich H-G (2001) Epidemiologie — Ätiologie der dilatativen Kardiomyopathie. Z Kardiol 90Suppl I: I/2–I/7
Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ (2001) Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 104:2517–2524
Pelliccia A, Fagard R, Bjornstad HH et al (2005) Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 26:1422–1445
Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P (1991) The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324:295–301
Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G (1996) Athlete’s heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA 276:211–215
Peters S, Peters H, Thierfelder L (1999) Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy. Int J Cardiol 71:243–250
Petersen SE, Selvanayagam JB, Francis JM, Myerson SG, Wiesmann F, Robson MD, Ostman-Smith I, Casadei B, Watkins H, Neubauer S (2005) Differentiation of athlete’s heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 7:551–558
Pires LA, Abraham WT, Young JB, Johnson KM (2006) Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: Results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Am Heart J 151:837–843
Pollick C (1982) Muscular subaortic stenosis: hemodynamic and clinic improvement after disopyramide. N Engl J Med 307:997–999
Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN (1987) Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J 114:148–152
Rees K, Taylor RS, Singh S, Coats AJ, Ebrahim S (2004) Exercise based rehabilitation for heart failure. Cochrane Database Syst Rev CD003331
Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F, Bussani R, Silvestri F (1992) Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 70:1589–1595
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842
Rost R, Hollmann W (1983) Athlete’s Heart — a review of its historical assessment and new aspects. Int J Sports Med 4:147–165
Sharma S, Firozzi S, McKenna WJ (2001) Value of exercise testing in assessing clinical state and prognosis in hypertrophic cardiomyopathy. Cardiol Rev 9:70–76
Sharma S, Maron BJ, Whyte G, Firozzi S, Elliott PM, McKenna WJ (2002) Physiologic limits of left ventricular hypertrophy in elite junior athletes: Relevance to differential diagnosis of athlete’s heart and hypertrophic cardiomyopathy. J Am Coll Cardiol 40:1431–1436
Spirito P, Rapezzi C, Bellone P, Betocchi S, Autore C, Conte MR, Bezante GP, Bruzzi P (1999) Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation 99:2132–2137
Spirito P, Seidman CE, McKenna W, Maron BJ (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336:775–785
St. John-Sutton MG, Lie JT, Anderson KR, O’Brien PC, Frye RL (1980) Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J 44:433–443
Sugrue DD, Rodeheffer RJ, Codd MB, Ballard DJ, Fuster V, Gersh BJ (1992) The clinical course of idiopathic dilated cardiomyopathy: A population-based study. Ann Intern Med 117:117–123
Takagi E, Yamakado T, Nakano T (1999) Prognosis of completely asymptomatic adult patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 33:206–211
Takeichi Y, Yokota M, Iwase M, Izawa H, Nishizawa T, Ishiki R, Somura F, Nagata K, Isobe S, Noda A (2001) Biphasic changes in left ventricular end-diastolic pressure during dynamic exercise in patients with nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 38:335–343
Thomson HL, Morris-Thurgood J, Atherton J, Frenneaux M (1998) Reduced cardiopulmonary baroreflex sensitivity in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 31:1377–1382
Turrini P, Corrado D, Basso C, Nava A, Bauce B, Thiene G (2001) Dispersion of ventricular depolarization-repolarization — A noninvasive marker for risk stratification in arrhythmogenic right ventricualar cardiomyopathy. Circulation 103: 3075–3080
Urhausen A, Kindermann W (1992) Echocardiographic findings in strength-and endurance-trained athletes. Sports Med 13:270–284
Urhausen A, Monz T, Kindermann W (1997) Echocardiographic criteria of physiological hypertrophy in combined strength-and endurance-trained athletes. Int J Card Imaging 13:43–52
Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG (1995) Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 27:641–647
Van Tol BAF, Huijsmans RJ, Kroon DW, Schothorst M, Kwakkel G (2006) Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta-analysis. Eur J Heart Fail 8:841–850
Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ (2001) Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 88:275–279
Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O’Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE (1995) Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332:1058–1064
Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithart G (1992) Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: results in patients with inducible and noninducible ventricular tachycardia. Circulation 86:29–37
Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, Breithart G (1994) Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy. Circulation 89:667–683
Yoshida N, Ikeda H, Wada T, Matsumoto A, Maki S, Muro S, Shibata A, Imaizumi T (1998) Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 32: 1938–1942
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Steinkopff Verlag Darmstadt
About this chapter
Cite this chapter
Nieß, A. (2007). Kardiomyopathien. In: Sportkardiologie. Steinkopff. https://doi.org/10.1007/978-3-7985-1707-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1707-3_9
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1706-6
Online ISBN: 978-3-7985-1707-3
eBook Packages: Medicine (German Language)